Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Dec;35(Suppl 3):978-982.
doi: 10.1007/s11606-020-06260-9. Epub 2020 Nov 3.

A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference

Affiliations
Editorial

A Research Agenda for Advancing Strategies to Improve Opioid Safety: Findings from a VHA State of the Art Conference

William C Becker et al. J Gen Intern Med. 2020 Dec.

Abstract

US military Veterans have been disproportionately impacted by the US opioid overdose crisis. In the fall of 2019, the Veterans Health Administration (VHA) convened a state-of-the-art (SOTA) conference to develop research priorities for advancing the science and clinical practice of opioid safety, including both use of opioid analgesics and managing opioid use disorder. We present the methods and consensus recommendations from the SOTA. A core group of researchers and VA clinical stakeholders defined three areas of focus for the SOTA: managing opioid use disorder, long-term opioid therapy for pain including consideration for opioid tapering, and treatment of co-occurring pain and substance use disorders. The SOTA participants divided into three workgroups and identified key questions and seminal studies related to those three areas of focus. The strongest recommendations included testing implementation strategies in the VHA for expanding access to medication treatment for opioid use disorder, testing collaborative tapering programs for patients prescribed long-term opioids, and larger trials of behavioral and exercise/movement interventions for pain among patients with substance use disorders.

PubMed Disclaimer

Conflict of interest statement

Dr. Weiss has consulted to Janssen Pharmaceuticals, Takeda Pharmaceuticals, Cerevel Therapeutics, and Analgesic Solutions. Other authors report no conflicts of interest.

References

    1. Lin L, Peltzman T, McCarthy JF, Oliva EM, Trafton JA, Bohnert ASB. Changing Trends in Opioid Overdose Deaths and Prescription Opioid Receipt Among Veterans. Am J Prev Med. 2019;57(1):106–10. doi: 10.1016/j.amepre.2019.01.016. - DOI - PubMed
    1. Salas J, Scherrer JF, Schneider FD, Sullivan MD, Bucholz KK, Burroughs T, et al. New-onset depression following stable, slow, and rapid rate of prescription opioid dose escalation. Pain. 2017;158(2):306–12. doi: 10.1097/j.pain.0000000000000763. - DOI - PMC - PubMed
    1. Chou R, Turner JA, Devine EB, Hansen RN, Sullivan SD, Blazina I, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162(4):276–86. doi: 10.7326/M14-2559. - DOI - PubMed
    1. Edelman EJ, Gordon KS, Crothers K, Akgün K, Bryant KJ, Becker WC, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019;179(3):297-304. - PMC - PubMed
    1. Gellad WF, Good CB, Shulkin DJ. Addressing the opioid epidemic in the United States: lessons from the Department of Veterans Affairs. JAMA Intern Med. 2017;177(5):611–2. doi: 10.1001/jamainternmed.2017.0147. - DOI - PubMed

Publication types

MeSH terms

Substances